Generative AI in Clinical Trial Market
- 2026 年市場規模
- USD 685.4 Mn
- 2033 年預估規模
- USD 4,276.8 Mn
- 年複合成長率 CAGR
- 29.9%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Generative AI in Clinical Trial Market, By Component (Software Platforms, Services), By Deployment (Cloud-Based, On-Premise), By Application (Regulatory Documentation and Medical Writing, Patient Recruitment and Enrollment, Clinical Data Management and Analytics, Protocol Design and Trial Planning, Pharmacovigilance and Safety Monitoring, Others), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutions, Healthcare Providers and Clinical Research Centers, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global generative AI in clinical trial market is estimated to be valued at USD 685.4 Mn in 2026 and is expected to reach USD 4,276.8 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 29.9% from 2026 to 2033. The market for generative AI in clinical trial is redefining research in pharma and its drug development pipeline. Generative AI is speeding up clinical trials by refining the clinical trial design, patient recruitment and selection, producing synthetic data, and accelerating trial processes using its ML and NLP functionalities, thus increasing operational efficiency, improving data accuracy, and ensuring regulatory compliance throughout the lifecycle of a clinical trial.
Due to increasing demand and the need for reduced drug development time and the number of approvals, the demand for generative AI has gone up throughout both pharmaceutical and biotech fields and the application for generative AI in the fields are protocol optimization, patient stratification, generation of real-world evidence, predictive analytics and the documentation of regulatory information.
Market Dynamics
The global generative AI in clinical trial market is driven by increasing cost, complexity, and time for drug development traditionally. With the proliferation of generative AI, the pharmaceutical and biotechnology companies have increasingly adapted to optimize trial designs, enhance patient enrollment, forecast the results of a treatment, and simplify the data analysis part. The growing volume of data, including electronic health records (EHRs), real-world evidence, and digital health data, further enable the use of AI in clinical research.
However, the growth of generative AI in clinical trial market is limited by factors such as data privacy concerns, regulatory approval of the AI derived insights, and a high implementation cost of sophisticated AI infrastructure. Nevertheless, burgeoning demand from personalized medicine, decentralized clinical trials, and AI-driven patient monitoring would bring ample opportunities for market growth. As the clinical research industry undergoes a digital revolution, generative AI will hold a growing place to boost the efficiency and effectiveness of clinical trials.
Key Features of the Study
• This report provides in-depth analysis of the global generative AI in clinical trial market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global generative AI in clinical trial market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medidata Solutions, Unlearn.ai, ConcertAI, Tempus AI, Phesi, AiCure, Lokavant, H1, TrialX, and NetraMark Holdings Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global generative AI in clinical trial market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global generative AI in clinical trial market
Market Segmentation
• Component Insights (Revenue, USD Mn, 2021 - 2033)
o Software Platforms
o Services
• Deployment Insights (Revenue, USD Mn, 2021 - 2033)
o Cloud-Based
o On-Premise
• Appication Insights (Revenue, USD Mn, 2021 - 2033)
o Regulatory Documentation and Medical Writing
o Patient Recruitment and Enrollment
o Clinical Data Management and Analytics
o Protocol Design and Trial Planning
o Pharmacovigilance and Safety Monitoring
o Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Pharmaceutical and Biotechnology Companies
o Contract Research Organizations (CROs)
o Academic and Research Institutions
o Healthcare Providers and Clinical Research Centers
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Medidata Solutions
o Unlearn.ai
o ConcertAI
o Tempus AI
o Phesi
o AiCure
o Lokavant
o H1
o TrialX
o NetraMark Holdings Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Generative AI in Clinical Trial Market, By Component
Global Generative AI in Clinical Trial Market, By Deployment
Global Generative AI in Clinical Trial Market, By Application
Global Generative AI in Clinical Trial Market, By End User
Global Generative AI in Clinical Trial Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Industry Trends
4. Global Generative AI in Clinical Trial Market, By Component, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Software Platforms
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Generative AI in Clinical Trial Market, By Deployment, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Cloud-Based
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o On-Premise
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Generative AI in Clinical Trial Market, By Application, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Regulatory Documentation and Medical Writing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Patient Recruitment and Enrollment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Clinical Data Management and Analytics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Protocol Design and Trial Planning
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Pharmacovigilance and Safety Monitoring
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Generative AI in Clinical Trial Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Pharmaceutical and Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Contract Research Organizations (CROs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Academic and Research Institutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Healthcare Providers and Clinical Research Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Generative AI in Clinical Trial Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
9. Competitive Landscape
o Medidata Solutions
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Unlearn.ai
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o ConcertAI
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Tempus AI
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Phesi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o AiCure
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Lokavant
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o H1
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o TrialX
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o NetraMark Holdings Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on Generative AI in Clinical Trial Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們